These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 1690209)

  • 1. Biological agents in cancer therapy: cytokines, monoclonal antibodies and vaccines.
    Oettgen HF
    J Cancer Res Clin Oncol; 1990; 116(1):116-9. PubMed ID: 1690209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytokines in clinical use].
    Meyer P; Wilms K
    Internist (Berl); 1988 Nov; 29(11):717-26. PubMed ID: 2466805
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological response modifiers: the new immunotherapy.
    Foon KA
    Cancer Res; 1989 Apr; 49(7):1621-39. PubMed ID: 2466558
    [No Abstract]   [Full Text] [Related]  

  • 4. Biologic agents and approaches in the management of patients with lymphoma. A critical appraisal.
    Longo DL
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):1067-87. PubMed ID: 1718939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferons and cytokines.
    Luger TA
    Curr Probl Dermatol; 1989; 18():269-76. PubMed ID: 2472932
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biotherapy of cancer].
    Subirá ML; Brugarolas A
    Rev Clin Esp; 1992 Jun; 191(2):102-8. PubMed ID: 1380172
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic properties of biological response modifiers. A discussion of preclinical and clinical studies.
    Talmadge JE
    Contrib Gynecol Obstet; 1989; 17():49-62. PubMed ID: 2495895
    [No Abstract]   [Full Text] [Related]  

  • 8. New therapeutic modalities for cancer.
    Thomas H; Sikora K
    Acta Oncol; 1991; 30(1):107-20. PubMed ID: 1706927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologics as cancer treatment modalities.
    Smalley RV
    Wis Med J; 1987 Nov; 86(11):19-21. PubMed ID: 2447705
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytokines in cancer therapy.
    Parkinson DR
    Urology; 1989 Oct; 34(4 Suppl):69-74; discussion 87-96. PubMed ID: 2477937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines and immunological monitoring.
    Sosman JA; Sawhaney A
    Cancer Chemother Biol Response Modif; 1997; 17():217-86. PubMed ID: 9551216
    [No Abstract]   [Full Text] [Related]  

  • 12. [Monoclonal antibodies and mediators--immunologic tumor therapy].
    Baron D
    Naturwissenschaften; 1990 Sep; 77(9):405-11. PubMed ID: 1701222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological response modifiers and cancer treatment].
    Urushizaki I
    Gan No Rinsho; 1989 Jan; Spec No():25-33. PubMed ID: 2464707
    [No Abstract]   [Full Text] [Related]  

  • 14. Overview of advances in the use of biological proteins in human cancer.
    Gutterman J
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):2-6. PubMed ID: 2461593
    [No Abstract]   [Full Text] [Related]  

  • 15. New antineoplastic therapies and inherent risks: monoclonal antibodies, biologic response modifiers and interleukin-2.
    Dillman JB
    J Intraven Nurs; 1989; 12(2):103-13. PubMed ID: 2475596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphokines and cytokines.
    Wagstaff J; Melief KJ
    Cancer Chemother Biol Response Modif; 1987; 9():432-53. PubMed ID: 2484327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of biotherapy in multiple myeloma].
    Petrucci MT; Tafuri A; Mandelli F
    Recenti Prog Med; 2000 Oct; 91(10):488-93. PubMed ID: 11072735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quadruple immunotherapy of Bacillus Calmette-Guérin, interferon, interleukin-2, and granulocyte-macrophage colony-stimulating factor as salvage therapy for non-muscle-invasive bladder cancer.
    Steinberg RL; Nepple KG; Velaer KN; Thomas LJ; O'Donnell MA
    Urol Oncol; 2017 Dec; 35(12):670.e7-670.e14. PubMed ID: 28801026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokines and cytokines.
    Wagstaff J; Melief K
    Cancer Chemother Biol Response Modif; 1988; 10():416-33. PubMed ID: 2484321
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic immunomodulation.
    Galbraith GM
    Dermatol Clin; 1988 Oct; 6(4):561-8. PubMed ID: 2465856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.